Memorial Hospital Research Laboratories
The Tobias Hohl Lab
Research
Professor
We investigate the immune response to human fungal pathogens and, conversely, the mechanisms that enable fungi to cause infectious diseases. To illuminate these processes, we generate fluorescent-based tools to monitor the outcome of fungal cell – host cell encounters and examine the role of both inhaled fungal spores and of endogenous fungal communities, termed the mycobiome, in fungal disease development.
Featured News
Publications Highlights
People
Tobias M. Hohl, MD, PhD
Chief, Infectious Diseases Service
Professor
- Physician-scientist Tobias Hohl studies the molecular pathogenesis of human fungal pathogens and how the immune system responds to them.
- MD, Weill Medical College of Cornell University
- PhD, Weill Graduate School of Medical Sciences of Cornell University
- [email protected]
- Email Address
- View physician profile
- Physician profile
Members
- Stony Brook University
- UT Southwestern Medical Center, Dallas, TX
- Weill Cornell Graduate School of Medical Sciences
- PhD, Tel Aviv University
- BS, Columbia University
Lab Alumni
Lab Affiliations
Achievements
- Fellow, American Academy of Microbiology (2021)
- Member, American Society of Clinical Investigation (2016)
- Investigator in the Pathogenesis of Infectious Diseases, Burrroughs Wellcome Fund (2014)
- Fellow, Infectious Diseases Society of America (2012)
- Young Investigator Award, American Society of Microbiology (2009)
Lab News & Events
Upcoming event
Novel Insights into Antifungal Immunity: From the Bench to the Bedside
Memorial Sloan Kettering Cancer Center
Zuckerman Research Center
417 East 68th Street
Room ZRC-105
New York, NY 10065
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs
Career Opportunities
Get in Touch
-
Lab Head Email
-
Lab Phone
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Tobias M. Hohl discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].